Sectors
AVIR
Atea Pharmaceuticals, Inc.
5.35
2 x 3.87
2 x 6.86
bid
ask
-
0.01
0.19%
2 @ 04:15 PM
5.35 +0.00 (0.00%)
| Ytd | 49.86% | |
| 1y | 59.23% |
5.32
day range
5.40
2.78
52 week range
6.45
| Open | 5.36 | Prev Close | 5.36 | Low | 5.32 | High | 5.40 | Mkt Cap | 429.10M |
| Vol | 198.43K | Avg Vol | 324.32K | EPS | -2.08 | P/E | N/A | Forward P/E | -2.12 |
| Beta | 0.17 | Short Ratio | 14.25 | Inst. Own | 71.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 4.90 | 200-d Avg | 4.55 | 1yr Est | 7.40 |
| Income Statement | |||
| Operating Expenses | 35.10M | ||
| Research and Development Expense | 28.15M | ||
| Selling, General and Administrative Expense | 6.95M | ||
| Operating Income | -35.10M | ||
| Income Tax Expense | 24.00K | ||
| Net Income | -32.93M | ||
| Net Income Common Stock | -32.93M | ||
| Net Income Common Stock (USD) | -32.93M | ||
| Consolidated Income | -32.93M | ||
| Earnings per Basic Share | -0.41 | ||
| Earnings per Basic Share (USD) | -0.41 | ||
| Earnings per Diluted Share | -0.41 | ||
| Earning Before Interest & Taxes (EBIT) | -32.91M | ||
| Earning Before Interest & Taxes (USD) | -32.91M | ||
| Weighted Average Shares | 80.05M | ||
| Weighted Average Shares Diluted | 80.05M | ||
| Balance Sheet | |||
| Cash and Equivalents | 76.55M | ||
| Cash and Equivalents (USD) | 76.55M | ||
| Investments | 142.92M | ||
| Investments Current | 142.92M | ||
| Current Assets | 228.67M | ||
| Property, Plant & Equipment Net | 569.00K | ||
| Total Assets | 232.28M | ||
| Debt Current | 424.00K | ||
| Total Debt | 424.00K | ||
| Current Liabilities | 28.12M | ||
| Total Liabilities | 28.12M | ||
| Accumulated Retained Earnings (Deficit) | -600.94M | ||
| Accumulated Other Comprehensive Income | -96.00K | ||
| Shareholders Equity | 204.16M | ||
| Shareholders Equity (USD) | 204.16M | ||
| Assets Non-Current | 3.62M | ||
| Total Debt (USD) | 424.00K | ||
| Trade and Non-Trade Payables | 10.06M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 104.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.77M | ||
| Net Cash Flow from Investing | 34.32M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 34.32M | ||
| Net Cash Flow from Operations | -37.08M | ||
| Share Based Compensation | 3.38M | ||